Clinical Trials Browser

OTHER × Myelodysplastic Syndromes × luspatercept × Clear all

NCT05732961 2026-05-05

Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms

Phase 2 Active not recruiting

Classical hematologyMyeloid

Anemia, Myelodysplastic Syndromes, Myeloproliferative Disorders